Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dong-A Enrolls GSK Korea General Manager On Board Of Directors; GSK Says Move Will Strengthen Alliance, Not Influence

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Korea's leading pharma Dong-A Pharmaceutical Co. Ltd. placed GlaxoSmithKline PLC's Korea General Manager Kim Jin-ho on its nine-member board of directors in a follow-up action to GSK's acquisition of a 9.9% stake in Dong-A in May 2010

You may also be interested in...

Otsuka Extends R&D MOU With Korea Until 2018

Otsuka is among six MNCs, including Pfizer, AstraZeneca, Novartis, Sanofi and Merck that have inked large R&D deals with Korea’s Ministry of Health.

Dong-A Wins Approvals From Otsuka, GSK For Split Into Holding Company

Dong-A Pharmaceutical is pushing to create a favorable environment for a temporary shareholder meeting on Jan. 28, though the third-largest shareholder, the National Pension Service, is opposed to a proposal to float a holding company.

Twelve Indicted In $4.53 Million Rebate Case Involving Korea’s Dong-A

Instead of providing rebates through its own sales representatives, Korea’s largest domestic company tried to sidestep anti-rebate laws using marketing and distribution agencies to provide rebates to hospitals and doctors.

Related Content




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts